The Cannigma

JUNE 14, 2021

‘Junk’ cannabis ‘ill-suited for clinical trials’. The cannabis grown at the University of Mississippi “is junk, ill-suited for clinical trials, and genetically closer to hemp than the marijuana available from dispensaries and used by Americans nationwide,” according to the lawsuit.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

NORML

OCTOBER 21, 2019

The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. Since 1968, the agency has only licensed the University of Mississippi to engage in the growing of cannabis for FDA-approved clinical research.

DEA 103

DEA Cultivation Clinical Trials Policy 103

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

JANUARY 11, 2023

Not only this, but Gaize recently completed the largest clinical trial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. How do you feel about this being the largest cannabis impairment clinical trial ever? Does Gaize plan on carrying out any future clinical trials?

Clinical Trials 98

Clinical Trials THC Data Safety 98

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Drugs: Education, Prevention and Policy , 28 (3), 211–214. Madison Natarajan, MS. – August 5, 2021. Thrul, J., & Garcia-Romeu, A. link] (Link). Source: [link].

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Law Report

SEPTEMBER 10, 2021

We’re thrilled to be working with a company that shares our vision and is committed to making Europe a leader in the field by providing world-class clinical expertise tailored to the nuances of psychedelic therapy.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

NORML

JANUARY 4, 2019

Separate provisions in the bill exclude cannabidiol from the federal definition of marijuana, permit VA doctors to authorize medical cannabis access to qualified patients, and remove undue federal barriers to clinical trial research to better assess the safety and efficacy of medical cannabis. Pennsylvania.

Legislation 122

Legislation Clinical Trials Research and Development Access 122

Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. (“Shanti”), and all its assets focused on psychedelic MDMA-based drug development. from 2020 to 2030 and generate revenue of $151.7

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

SpeedWeed

JULY 6, 2021

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . Harvard’s new center will be the first to focus solely on psychedelics policy and laws rather than research, though. View original article.

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Here’s the press release. The Project on Psychedelics Law and Regulation (POPLAR).

Law 59

Law Policy Research and Development Clinical Trials 59

Otherside Farms

JANUARY 25, 2019

Norman Smith: “Since I am the only successful patient in the clinical trial, to take away something that’s been part of a successful regimen does not make any sense” In September 2010, Smith became eligible for a liver transplant, but after testing positive for marijuana in February he was removed from the transplant list.

Patients 76

Patients Clinical Trials Marijuana Policy 76

Veriheal

MARCH 20, 2023

Psilocybin Policies Around the Nation Let’s explore where psilocybin is legal, decriminalized, and on the ballot across U.S. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Legal Colorado and Oregon are the only states allowing legal therapeutic psilocybin use today.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Veriheal

JULY 16, 2020

Despite the novelty of its drug policy findings, the document has gone largely unnoticed by reform advocates and the media. federal government’s policies have blocked externally valid, randomized clinical trials on the effects of cannabis,” the report says.

Research and Development 97

Research and Development Clinical Trials Treatment Compliance 97

Cannabis Law Report

JULY 29, 2021

of their dry weight and it is not practical to obtain meaningful pure amounts of these compounds from the flesh of mushrooms, at a reasonable cost, to conduct clinical trials in humans and to commercialize these products. The levels of these compounds in dried mushrooms are only 0.2% – 1.0%

Clinical Trials 105

Clinical Trials Conditions Packaging Events 105

Cannabis Law Report

FEBRUARY 10, 2022

Congress passed the RTT Act in 2018 to give qualifying patients access to investigational drugs outside of a clinical trial setting. Psilocybin successfully completed an FDA-approved Phase 1 clinical trial in 2019, and two companies, COMPASS Pathways and Usona, both currently have Phase 2 trials ongoing.

DEA 52

DEA Clinical Trials Policy Research and Development 52

The Cannigma

AUGUST 31, 2021

A 2018 research paper in the International Journal of Drug Policy analyzed in-depth interviews carried out with 24 Israeli physicians working in pain medicine, oncology, and family medicine, and found that “physicians discussed contrasting narratives of cananbi, presenting it as both a medicine and non-medicine.”

Education 101

Education Clinical Trials Medicine Policy 101

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Representative Lou Correa (D-CA) this week introduced HR 493: The Sensible Enforcement Of Cannabis Act, which would codify the protections that were outlined in the now-rescinded Cole Memo.

Legislation 189

Legislation Decriminalization Access Therapy 189

Veriheal

MAY 12, 2021

In light of such, and the fact that cancer is a common qualifying condition for cannabis, this research team took to expanding the available basic information on cannabis in the cancer population in order to provide clinical trial designers with better information needed for planned studies.

Patients 98

Patients Consumption Clinical Trials Education 98

Cannabis Law Report

NOVEMBER 19, 2021

“These additional patent filings are key as PsyBio moves towards the initiation of appropriately approved safety and efficacy clinical trials for our selected compounds within the production and manufacturing arena, for the Company as well as for our investors.” Vigorous scientific research and clinical trials are needed.

Clinical Trials 52

Clinical Trials Research and Development Events Safety 52

Cannabis Law Report

JUNE 24, 2022

And the fact that the legislation is originating from leadership who is intimately familiar with drug policy reform is a firm indicator that this is a serious endeavor. Full story at. New Jersey Senate President Files Psilocybin Legalization Bill That Includes Home Grow Option, Unlike Current Marijuana Law.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 16, 2021

House lawmakers have introduced a series of drug policy-related amendments to defense legislation, including proposals to facilitate research on the benefits of psychedelics for active duty military personnel and to protect banks that service state-legal marijuana businesses. Marijuana Moment reports.

Banking 52

Banking Clinical Trials Chronic Pain Marijuana 52

Cannabis Law Report

APRIL 27, 2022

MDMA-assisted therapy has already shown incredible results in the stage three clinical trials for individuals suffering from severe PTSD,” Ginal told committee members. “I Patrick Neville (R) and David Ortiz (D), along with Sens. John Cooke (R) and Joann Ginal (D). I ask for your support on this bill.”.

Clinical Trials 52

Clinical Trials Legalization Therapy Food 52

Weedistry

FEBRUARY 4, 2019

One of the most common arguments against the efficacy of medical cannabis today is that public policy is outpacing real science. Just because we don’t yet have clinical trial results that confirm medical cannabis relieves pain, or eases insomnia, or reduces inflammation, etc., That’s simply not true.

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

CannaTech

JANUARY 27, 2019

From clinical trials to cosmetics, the region is gearing up for high return and low cost of production. Companies and investors are actively building relationships with products, people, plants and policies. land, labs, licenses). That’s not the only high, low combo to note.

Clinical Trials 81

Clinical Trials Cultivation Research and Development Pharmaceutical 81

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? Seventy-six mostly male veterans between the ages of 24 and 77 completed the Phase 1 trial. Co-author Dr Sue Sisley says that the results are promising.

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

Veriheal

MARCH 23, 2023

The report states that the revision is an essential move for ensuring the legal use of cannabis-derived epilepsy drug Epidiolex , which is currently being reviewed as part of a series of clinical trials in Japan.

Legalization 82

Legalization Marijuana Clinical Trials Seed-To-Sale 82

Cannabis Law Report

JUNE 10, 2021

Marijuana policies in the United States have become more permissive, motivating research on demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use. Marijuana policies in the United States (U.S.) Introduction.

Policy 45

Policy Safety Marijuana Data 45

Cannabis Law Report

SEPTEMBER 23, 2022

Going forward, MAPS will focus on advocating for psychedelic policy reform to include state funding for public education, harm reduction, and unarmed crisis response services. On the heels of the update about SB 519 was news of Governor Gavin Newsom vetoing another proposed piece of drug policy legislation sponsored by Senator Wiener.

Decriminalization 52

Decriminalization Advocacy Research and Development Clinical Trials 52

Cannabis Law Report

OCTOBER 10, 2021

Provide guidance on clinical trials and plays integral role in bringing new product innovations to different markets in Europe (and beyond). Manage compliance to global, regional and local processes, policies, SOPs and working instructions. YOUR PROFILE: Bachelor’s degree in life science, relevant scientific field required (e.g.

Clinical Trials 52

Clinical Trials Therapy Medicine Pharmaceutical 52

Cannabis Law Report

OCTOBER 4, 2021

A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions. This is a policy where the federal government, the DEA, will refrain from taking prosecutorial action if state law permits, regulates, and carefully controls the use of a drug.

Therapy 52

Therapy Patients Law Clinical Trials 52

United Patients Group

JANUARY 8, 2023

In order to get involved in research, you can look up clinical trials in your area that may be accepting volunteers. The time is ripe for more research on this front, especially as more countries move towards legalizing medical marijuana.

Blood Pressure 122

Blood Pressure Sleep Cannabinoids Clinical Trials 122

Cannabis Law Report

SEPTEMBER 22, 2021

Despite this, the Home Office “fails to act, perpetuating what can be considered the worst research blackout in scientific history,” according to the Conservative Drug Policy Reform Group (CDPRG), of which Mr Blunt is chairman.

Research and Development 52

Research and Development Clinical Trials Treatment History 52

MMJ Recs

MAY 9, 2024

The proposed legislation seeks to amend existing laws and policies to allow VA healthcare providers to discuss medical marijuana with patients, conduct research on its efficacy, and prescribe medical cannabis in states where it is legal. Any questions related to research can be addressed to VHABLRD-CSRD@va.gov.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Project CBD

FEBRUARY 28, 2023

13 Although many review authors reported inconclusive findings due to low-quality studies, they noted that evidence from human clinical trials seems to support CBD’s positive effects on nociceptive pain (i.e., 17 Excerpted from HerbalGram , the quarterly publication of the American Botanical Council.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

APRIL 21, 2022

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine and profiled on the front page of The New York Times. The State Government Affairs Lead will oversee MAPS PBC’s policy efforts at the state level. Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Clinical Trials Safety 52

CannaMD

MARCH 8, 2021

Journal of Economic Analysis & Policy , and Journal of Drug Issues all report drops in crime following marijuana legalization. Then in 1975, the FTC sued the AMA, claiming the organization’s anti-marketing policy constituted unreasonable “restraint of trade.”. Importantly, the Journal of Economic Behavior & Organization , B.E.

THC 116

THC Research and Development Treatment Patients 116